VIVO ISARTM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VIVO ISARTM, covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention. [NA]